Newswise — Macrophages are best known for their Pac Man–like ability to gobble up cellular debris and pathogens in order to thwart infection. A new study in The Journal of Cell Biology describes how these immune cells also help resolve inflammation by inducing white blood cells called neutrophils to leave wounded tissue.
Neutrophils are “first responders” that are attracted to wounds by signaling molecules called reactive oxygen species (ROS) that activate a protein kinase. When neutrophils finish their work, inflammation is partly resolved through apoptosis, or cell suicide, and the subsequent engulfment of the neutrophils’ remains by macrophages. But neutrophils can also elect to leave wounded tissue in a process known as reverse migration. Whether macrophages promote this mode of inflammation resolution is unclear.
Taking advantage of transparent zebrafish larvae, Anna Huttenlocher and colleagues from the University of Wisconsin-Madison found that neutrophils were generally recruited to wounds before macrophages, but, once they arrived, macrophages often contacted neutrophils and appeared to shepherd them away from the damaged tissue. Neutrophils remained in wounds for longer times in zebrafish larvae lacking macrophages, the researchers discovered. Like neutrophils, macrophages were attracted to wounds by ROS and protein kinase signaling, and macrophages lacking the ROS-generating enzyme Nox2 were unable to migrate into wounds and induce the departure of neutrophils.
Interestingly, patients lacking the human equivalent of Nox2 suffer from recurring infections and exaggerated inflam-mation, a disorder known as chronic granulomatous disease. This new study suggests that one cause of the patients’ symptoms may be the inability of macrophages to migrate to sites of inflammation to induce neutrophil reverse migration and inflammation resolution.
# # #
Tauzin, S., et al. 2014. J. Cell Biol. doi: 10.1083/jcb.201408090
About The Journal of Cell Biology The Journal of Cell Biology (JCB) is published by The Rockefeller University Press. All editorial decisions on manuscripts submitted are made by active scientists in conjunction with our in-house scientific editors. JCB content is posted to PubMed Central, where it is available to the public for free six months after publication. Authors retain copyright of their published works, and third parties may reuse the content for non-commercial purposes under a creative commons license. For more information, please visit www.jcb.org.
Research reported in the press release was supported by the American Heart Association and National Institutes of Health.